Lysosomes as dynamic regulators of cell and organismal homeostasis

A Ballabio, JS Bonifacino - Nature reviews Molecular cell biology, 2020 - nature.com
Exciting new discoveries have transformed the view of the lysosome from a static organelle
dedicated to the disposal and recycling of cellular waste to a highly dynamic structure that …

Disruption of axonal transport in neurodegeneration

SH Berth, TE Lloyd - The Journal of Clinical Investigation, 2023 - Am Soc Clin Investig
Neurons are markedly compartmentalized, which makes them reliant on axonal transport to
maintain their health. Axonal transport is important for anterograde delivery of newly …

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease

C Depp, T Sun, AO Sasmita, L Spieth, SA Berghoff… - Nature, 2023 - nature.com
The incidence of Alzheimer's disease (AD), the leading cause of dementia, increases rapidly
with age, but why age constitutes the main risk factor is still poorly understood. Brain ageing …

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease

S Forner, S Kawauchi, G Balderrama-Gutierrez… - Scientific data, 2021 - nature.com
Mouse models of human diseases are invaluable tools for studying pathogenic mechanisms
and testing interventions and therapeutics. For disorders such as Alzheimer's disease in …

Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model

P Zhang, Y Kishimoto, I Grammatikakis… - Nature …, 2019 - nature.com
Neuritic plaques, a pathological hallmark in Alzheimer's disease (AD) brains, comprise
extracellular aggregates of amyloid-beta (Aβ) peptide and degenerating neurites that …

A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer's disease

Y Yoo, G Neumayer, Y Shibuya, MMD Mader… - Cell stem cell, 2023 - cell.com
Alzheimer's disease (AD) remains one of the grand challenges facing human society. Much
controversy exists around the complex and multifaceted pathogenesis of this prevalent …

[HTML][HTML] Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy

T Wu, B Dejanovic, VD Gandham, A Gogineni… - Cell reports, 2019 - cell.com
Complement pathway overactivation can lead to neuronal damage in various neurological
diseases. Although Alzheimer's disease (AD) is characterized by β-amyloid plaques and tau …

Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model

E Spangenberg, PL Severson, LA Hohsfield… - Nature …, 2019 - nature.com
Many risk genes for the development of Alzheimer's disease (AD) are exclusively or highly
expressed in myeloid cells. Microglia are dependent on colony-stimulating factor 1 receptor …

A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease

P Zhao, Y Xu, LL Jiang, X Fan, L Li, X Li… - Science translational …, 2022 - science.org
Triggering receptor expressed on myeloid cells 2 (TREM2) plays crucial roles in Alzheimer's
disease (AD) by regulating microglia migration toward, and phagocytosis of oligomeric …

β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer's disease model mice

Y Zhao, Q Zheng, Y Hong, Y Gao, J Hu, M Lang… - Nature …, 2023 - nature.com
Extensive studies indicate that β-amyloid (Aβ) aggregation is pivotal for Alzheimer's disease
(AD) progression; however, cumulative evidence suggests that Aβ itself is not sufficient to …